{
  "id": "neuroem-therapeutics-appoints-dr-w-scott-burgin-as-chief-medical-officer",
  "title": "NeuroEM Therapeutics appoints Dr. W. Scott Burgin as Chief Medical Officer",
  "summary": "NeuroEM Therapeutics, a clinical-stage biotechnology company developing non-drug bioengineered approaches to cognitive decline and Alzheimer’s disease, announced the appointment of Dr. W. Scott Burgin, MD, as its first Chief Medical Officer (CMO). Dr. Burgin has been a long-time medical advisor to NeuroEM prior to this role, and brings decades of experience in neurology, clinical care, […] The post NeuroEM Therapeutics appoints Dr. W. Scott Burgin as Chief Medical Officer appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/neuroem-therapeutics-appoints-dr-w-scott-burgin-as-chief-medical-officer/",
  "source": "Longevity.Technology",
  "author": null,
  "category": "news",
  "publishedAt": "2026-02-02T03:36:06.000Z",
  "fetchedAt": "2026-02-04T10:49:05.817Z",
  "relevanceScore": 0.4,
  "matchedKeywords": [
    "longevity",
    "alzheimer"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.867Z"
}